12
Peer Review for Paediatric Diabetes Ruth Bridgeman

Peer Review for Paediatric Diabetes

Embed Size (px)

DESCRIPTION

Peer Review for Paediatric Diabetes. Ruth Bridgeman. The New Health Environment. Benefits of Peer Review. Provision of disease specific information across the country together with information about individual teams which has been externally validated Provision of benchmark data - PowerPoint PPT Presentation

Citation preview

Page 1: Peer Review for Paediatric Diabetes

Peer Review for Paediatric DiabetesRuth Bridgeman

Page 2: Peer Review for Paediatric Diabetes

The New Health EnvironmentThe New Health Environment

Page 3: Peer Review for Paediatric Diabetes

Benefits of Peer ReviewBenefits of Peer Review

• Provision of disease specific information across the country together with information about individual teams which has been externally validated

• Provision of benchmark data

• Provision of a catalyst for change and service improvement

• Identification and resolution of immediate risks to patients and or staff

• Engagement of a substantial number of front line clinicians in reviews

Page 4: Peer Review for Paediatric Diabetes

Benefits of Peer ReviewBenefits of Peer Review

• Clinical support for a peer review

• Enabled rapid sharing of learning between clinicians, as well as a better understanding of :

– Commissioning Services for Children and Young People with Diabetes– Delivering the Diabetes National Service Framework

Page 5: Peer Review for Paediatric Diabetes

MeasuresMeasures

Methodology – Developed by a small expert group– Fiona Campbell / Philip Holland– Ian Manifold, Ruth Bridgeman and James Heasman

Developmental – Unlikely to achieve 100% in the first round of review– Opportunity to test with the pilot– Looking to share good practice

Organisational Approach– Network Level– Hospital Level– MDT Level

Page 6: Peer Review for Paediatric Diabetes

MeasuresMeasures

D11-1A-100– CYPDN MEASURESMeasureNumber

 

D11-1A-101 Chair of the CYPDND11-1A-102 Membership and terms of reference of the CYPDND11-1A-103 CYPDN MeetingsD11-1A-104 CYPDN Annual ReportD11-1A-105 CYPDN proposals for service developmentD11-1A-106 The Configuration of MDTs within the CYPDND11-1A-107 Clinical GuidelinesD11-1A-108 Agreed Network wide diabetes minimum dataset (MDS)D11-1A-109 Children and Young People Diabetes Network review of

progress against diabetes auditD11-1A-110 Twenty-four hour telephone service specification

Page 7: Peer Review for Paediatric Diabetes

MeasuresMeasuresD11-1D-100–HOSPITAL MEASURES FOR CHILDREN AND YOUNG PEOPLE DIABETES SERVICES

MeasureNumber

 

D11-1D-101Children and Young People diabetes service specification for patient access

D11-1D-102 Minimum consultation periodD11-1D-103 Availability of information in an Outpatient environmentD11-1D-104 Availability of ICU/HDUD11-1D-105

Review of Children and Young People admissions on a quarterly basis

Page 8: Peer Review for Paediatric Diabetes

MeasuresMeasuresD11-2A-100–CHILDREN AND YOUNG PEOPLE DIABETES MDT MEASURES

MeasureNumber

 

D11-2A-101 Lead Clinician and ResponsibilitiesD11-2A-102 CYPDN AttendanceD11-2A-103 CYPD MDT Core Team MembershipD11-2A-104 Extended team membershipD11-2A-105 Policy for patients to be discussed by the CYPD MDTD11-2A-106 Treatment planning meetingD11-2A-107 Cover arrangements for core membersD11-2A-108 Operational policy meetingD11-2A-109 Informing the GP of the diagnosis and initial prescribingD11-2A-110 Key worker policyD11-2A-111 Specialist training for core nurse memberD11-2A-112 List of responsibilities for core nurse membersD11-2A-113 Access to core CYPD MDT members for follow-up patientsD11-2A-114 Patients’ permanent consultation recordD11-2A-115 Patients’ experience exerciseD11-2A-116 Outcome of patients’ experience exerciseD11-2A-117 Provision of patient written informationD11-2A-118 Clinical guidelinesD11-2A-119 Policy for the management of patients whose HBA1c rating is greater than 9.5.D11-2A-120 Policy for the screening of children and young people with type 1 diabetesD11-2A-121 Policy for patient choice of insulin pump therapyD11-2A-122 Teaching of the principles of carbohydrate countingD11-2A-123 Training policy for new patientsD11-2A-124 Management transfer of young people to young adults clinicD11-2A-125 Data collectionD11-2A-126 Participation in auditD11-2A-127 Presentation and review of audit activity

Page 9: Peer Review for Paediatric Diabetes

HandbookHandbook

• This is the key document

• Explains the processes to be used for the pilot

Page 10: Peer Review for Paediatric Diabetes

Visit ProgrammeVisit Programme

Agree Pilot Visits – Network Visit– Calderdale– Bradford – Hull

Agree Dates– 28 March – Hull– 29 March – Calderdale– 30 March – Bradford– Network Visit to be confirmed

Page 11: Peer Review for Paediatric Diabetes

Visit ProgrammeVisit Programme• Letter’s to confirm visit to go the CEOs

• Self Assessment deadlines18 March 2011

• Pre visits1st 2nd 3nd March – if requested

• Visits–28 March – Hull–29 March – Calderdale–30 March – Bradford–Network Visit to be confirmed

Page 12: Peer Review for Paediatric Diabetes

Evaluation of the pilot Evaluation of the pilot ProgrammeProgramme• Report by the Quality Manager

– Details of the outcomes of the pilot– Evaluation of the pilot– Recommended next steps